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Abstract
Objective. To evaluate the efficacy of cerclage for preventing preterm birth in
twin pregnancies with a short cervical length. Design. We performed an individ-
ual patient data meta-analysis. Searches were performed in electronic databases.
Setting. Sidney Kimmel Medical College of Thomas Jefferson University, Phila-
delphia, PA, USA. Population. Twin pregnancies in mothers with short cervical
length. Methods. We performed an individual patient data meta-analysis of
randomized trials of twin pregnancies screened by transvaginal ultrasound in
second trimester and where mothers had a short cervical length <25 mm before
24 weeks. Eligible women had to be randomized to cerclage vs. no-cerclage
(control). Main outcome measures. The primary outcome was preterm
birth <34 weeks. Results. Three trials with 49 twin gestations with a short cervi-
cal length were identified. All original databases for each included trial were
obtained from the primary authors. Risk factors were similar in the cerclage and
control groups, except that previous preterm birth was more frequent and gesta-
tional age at randomization and delivery were earlier in the cerclage group com-
pared with the control group. Adjusting for previous preterm birth and
gestational age at randomization, there were no statistically significant differ-
ences in primary (adjusted odds ratio 1.17, 95% confidence interval 0.23–3.79)
and secondary outcomes. Rates of very low birthweight and of respiratory dis-
tress syndrome were significantly higher in the cerclage group than in the con-
trol group. Conclusion. Based on these Level 1 data, cerclage cannot currently be
recommended for clinical use in twin pregnancies with a maternal short cervical
length in the second trimester. Large trials are still necessary.
Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; CL, cervical
length; GA, gestational age; NICU, neonatal intensive care unit; PTB, preterm
birth; RCTs, randomized controlled trials; RR, relative risk; TVU, transvaginal
ultrasound.
Introduction
The incidence of twin gestations has increased, mostly
because of increased use of assisted reproductive technol-
Key Message
Cerclage does not prevent preterm birth in asymp-
tomatic twin gestations with a maternal short cervical
length on transvaginal ultrasound.
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ogies (1). Twin pregnancies are at increased risk of preterm
birth (PTB), which is the primary reason for their
increased morbidity and mortality compared with single-
ton pregnancies. Twins account for about 3% of all preg-
nancies in the USA, but constitute at least 10% of cases of
PTB (2), over 30% of very low birthweight infants, and are
associated with nearly 20% of infant mortality (3).
A short cervical length (CL) on transvaginal ultrasound
(TVU) has been shown to be a good predictor of PTB,
including twin pregnancies (4). In singleton pregnancies
with a previous PTB and a short CL < 25 mm before
24 weeks of gestation, cerclage was associated with signifi-
cant decreases in PTB and perinatal morbidity and mor-
tality in a meta-analysis of randomized controlled trials
(RCTs) (5). In contrast, the effect of cerclage in twins
with a short CL < 25 mm has been insufficiently studied,
with meta-analysis data showing a possible harm from
cerclage compared with controls (6).
The aim of this meta-analysis was to systematically
review all RCTs on cerclage for prevention of PTB in
women with asymptomatic twin gestations with a short
TVU CL, assessing possible confounders in demographic
characteristics, risk factors and subgroups for effects on
the incidence of PTB.
Material and methods
Searches were performed in MEDLINE, OVID, Scopus,
ClinicalTrials.gov, the PROSPERO International Prospec-
tive Register of Systematic Reviews, EMBASE and the
Cochrane Central Register of Controlled Trials with the
use of a combination of keywords and text words related
to “cerclage,” “cervical cerclage,” “short cervix,” “ultra-
sound” and “randomized trials” from 1966 until Septem-
ber 2014. No restrictions for language or geographic
location were applied. We did not exclude any trials
based on their publication status or language. This review
strategy has been cited to capture up to 97% of relevant
literature (7). We included RCTs of asymptomatic twin
gestations screened by TVU in the second trimester of
pregnancy and where the mothers were found to have a
short CL < 25 mm. Eligible women were randomized to
cerclage vs. no cerclage (control group). Exclusion criteria
were quasi-randomized trials, history-indicated cerclage,
twin-only-indicated cerclage, physical examination-indi-
cated cerclage and major fetal anomaly. For this the indi-
vidual patient data meta-analysis encompassed all original
databases for each included RCT as obtained from the
primary authors.
The primary outcome was predefined as PTB < 34
weeks of gestation. Secondary outcomes included PTB <
37 weeks, PTB < 35 weeks, PTB < 32 weeks, PTB < 28
weeks, PTB < 24 weeks, perinatal death, low birthweight
(defined as <2500 g), very low birthweight (defined as
<1500 g), respiratory distress syndrome, intraventricular
hemorrhage, necrotizing enterocolitis, sepsis, and neonatal
intensive care unit (NICU) admission.
We planned subgroup analyses in twin gestations with
previous PTB; twins without previous PTB; twins with
previous second trimester loss and twins with cone biopsy.
We planned to stratify results by gestational age at detec-
tion of the short CL. We also planned to examine the effect
limiting the analysis to women with CL ≤ 15 mm.
Before data extraction, the review was registered with
the PROSPERO International Prospective Register of Sys-
tematic Reviews (registration no. CRD42014013577) (8).
The risk of bias in each included study was assessed by
using the criteria outlined in the Cochrane Handbook
for Systematic Reviews of Interventions. Review authors’
judgments were categorized as “low risk,” “high risk” or
“unclear risk” of bias (9).
The data analysis was completed independently by the
authors (GS, VB) using REVIEW MANAGER 5.3 (Cochrane,
London, UK). The completed analyses were then compared
and any difference was resolved with review of the entire
data and independent analysis. The random effects model
of DerSimonian and Laird was used to obtain the pooled
risk ratios estimate. Pooled estimates were based on the
crude risk ratio. A logistic regression was performed to cor-
rect data for those variables significantly different between
groups. Results of the logistic analysis are presented as
adjusted odds ratio (aOR) with 95% confidence interval
(95% CI). The logistic regression was conducted using the
Statistical Package for Social Science (SPSS) software, Ver-
sion 20.0 (SPSS Inc., Chicago, IL, USA). The meta-analysis
was performed following the Preferred Reporting Item for
Systematic Reviews and Meta-analyses (PRISMA) state-
ment (10). There was no funding source.
Results
Eighteen randomized trials of cerclage in pregnancy were
identified (11–28). Fourteen were excluded because twin
gestations were not evaluated (11–17,22–28), and one was
excluded because it evaluated only history-indicated cerc-
lage (18). All three trials that included twin mothers with
short CL randomized to cerclage or control met the crite-
ria for inclusion in this meta-analysis and so were ana-
lyzed (19–21). No similar systematic reviews were found
during the search process. Figure 1 shows the flow dia-
gram of studies identified in the systematic review (PRIS-
MA template).
The risk of bias according to the Cochrane risk of bias
tool is shown in Figure 2. All studies had both adequate
random sequence generation and concealment allocation.
Incomplete outcome data and selective reporting were
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considered as having low risk of bias for all the studies
(Figure 2).
Pooled descriptive data are presented in Table 1. Of
the 49 twin gestations included in the three trials (19–
21), 24 (49%) were randomized to cerclage, with 25
(51%) randomized to the control groups (no cerclage).
Maternal characteristics were similar in the two groups
except for the rate of previous PTB, which was higher in
the cerclage group (25% vs. 4%, p = 0.049), and gesta-
tional age at randomization, which was earlier in the
cerclage group (21.46 weeks vs. 23.32 weeks, p = 0.019)
(Table 1). The gestational age at delivery was earlier in
the cerclage group (30.33 vs. 34.20 weeks, p = 0.007), but
there was no significant difference in latency from ran-
domization to delivery (8.8 vs. 10.9 weeks, p = 0.131). A
Forest plot of PTB < 34 weeks of gestation is shown in
Figure 3.
Figure 1. Flow diagram of studies identified in the systematic review
(PRISMA template).
(a) (b)
Figure 2. Assessment of risk of bias. (a) Summary of risk of bias for each trial; +, low risk of bias; , high risk of bias; ?, unclear risk of bias. (b)
Risk of bias graph about each risk of bias item presented as percentages across all included studies.






(n = 25) p-value
Maternal age (years),
mean  SD
28.88  5.40 28.08  6.35 0.640
Race, African-American 4 (16.7) 0 (0) 0.500
Previous PTB <37 weeks 6 (25.0) 1 (4.0) 0.049
Previous STL
(16–23 weeks)
3 (12.5) 0 (0) 0.110
M€ullerian anomalies 0 (0) 0 (0) –
Cone biopsy 2 (8.3) 4 (16.0) 0.667
Smoking 2 (8.3) 8 (32.0) 0.074
CL (cm) mean  SD 18.6  6.1 18.3  4.7 0.817
GA at randomization
(weeks), mean  SD
21.4  3.1 23.3  2.1 0.019
Data are presented as number (percentage).
CL, cervical length; GA, gestational age; PTB, preterm birth; SD, stan-
dard deviation; STL, second-trimester loss.
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Adjusting for confounders (previous PTB and gesta-
tional age at randomization), women who received cerc-
lage had a similar rate of PTB < 34 weeks compared with
the control group (62.5% vs. 24.0%; aOR 1.17, 95% CI
0.23–3.79) (Table 2). Most secondary outcomes, includ-
ing PTB < 37 weeks, PTB < 35 weeks, PTB < 32 weeks,
PTB < 28 weeks, PTB < 24 weeks, perinatal deaths, intra-
ventricular hemorrhage, sepsis and NICU admission were
similar in the two groups. Very low birthweight (aOR
2.22, 95% CI 1.07–5.73) and respiratory distress syn-
drome (aOR 3.88, 95% CI 1.09–21.03) were more fre-
quent in the cerclage group, though with borderline
significance. No data were available on necrotizing
enterocolitis (Table 2). There were no significant differ-
ences for PTB < 34 weeks in the subgroup analyses, once
adjusted for confounders (Table 3).
Discussion
This meta-analysis of pooled data of the three RCTs
evaluating the efficacy of cerclage in asymptomatic twin
gestations screened by TVU in the second trimester of
pregnancy and found to have a short CL < 25 mm,
shows that cerclage is not associated with prevention of
PTB compared with control women who do not receive a
cerclage suture. Women who had cerclage were random-
ized about 2 weeks earlier, and delivered about 4 weeks
earlier than the controls. We found no significant differ-
ence in the latency from randomization to delivery.
Regarding neonatal outcomes, women who received cerc-
lage had the same rate of perinatal deaths, low birth-
weight, intraventricular hemorrhage, NICU admission
and sepsis, compared with the control group. The rate of
very low birthweight and of respiratory distress syndrome
was higher in the cerclage group compared with the con-
trols. In the subgroup analyses we found no benefit or
detriment of cerclage in this population. Results for these
outcomes need to be interpreted with caution because of
the small numbers.
In our 2005 meta-analysis we reported on data
available at that time regarding ultrasound-indicated cerc-
lage, focusing mostly on singleton gestations, and on the
Figure 3. Meta-analysis of cerclage in twins and preterm birth at <34 weeks of gestation.
Table 2. Primary and secondary outcomes in all twin pregnancies.
Outcome
Cerclage (n = 24) Control (n = 25)
RR (95% CI) aOR (95% CI)n % n %
PTB < 37 weeks 22 91.7 19 76.0 1.18 (0.91–1.53) 1.13 (0.17–8.66)
PTB < 35 weeks 18 75.0 9 36.0 1.63 (0.88–3.02) 1.44 (0.66–7.11)
PTB < 34 weeks 15 62.5 6 24.0 2.19 (0.72–6.63) 1.17 (0.23–3.79)
PTB < 32 weeks 11 45.8 4 16.0 2.48 (0.96–6.37) 1.77 (0.88–3.39)
PTB < 28 weeks 7 29.2 2 8.0 2.62 (0.72–9.51) 1.66 (0.62–4.01)
PTB < 24 weeks 5 20.8 0 0 N/A N/A
Perinatal deaths 11/48 22.9 3/50 6.0 2.66 (0.83–8.54) 2.04 (0.55–8.32)
Low birthweight 42/48 87.5 29/50 58 1.39 (1.06–1.83) 1.23 (0.85–2.55)
Very low birthweight 25/48 52.1 7/50 14.0 3.31 (1.58–6.91) 2.22 (1.07–5.73)
Respiratory distress syndrome 15/48 31.3 3/50 6.0 5.07 (1.75–14.70) 3.88 (1.09–21.03)
Intraventricular hemorrhage 3/48 6.3 3/50 6.0 1.13 (0.27–4.74) 1.09 (0.21–4.98)
Sepsis 0/48 0 2/50 4.0 0.23 (0.01–4.58) 0.18 (0.01–5.68)
NICU 5/22 22.7 11/20 55.0 0.35 (0.06–2.12) 0.45 (0.12–2.49)
Logistic regression was performed to correct data for confounders (previous PTB, gestational age at randomization). Primary outcome was
PTB < 34 weeks of gestation.
aOR, adjusted odds ratio; N/A: not applicable; NICU: neonatal intensive care unit admission; PTB, preterm birth; RR, relative risk.
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differences between singleton pregnancies with or without
previous PTB (6). For twins, we reported only the rates
of PTB < 35 weeks and perinatal mortality, without look-
ing at any patient characteristic, risk factor, or other out-
come measures (6). Both the American Congress of
Obstetricians and Gynecologists and the Society of Mater-
nal and Fetal Medicine have reported on the subgroup
analysis data of that original meta-analysis on the
increased rate of PTB at <35 weeks of gestation in twins
with TVU CL < 25 mm who received cerclage compared
with controls (29,30). Since then, several colleagues have
asked for more details regarding these data, in particular
regarding assessing possible confounders in demographic
characteristics, risk factors and subgroups for effects on
the incidence of PTB in the cerclage compared with the
control groups just for twin gestations. As no new RCT
has been published since then regarding this issue, these
data remain the only available Level 1 data on the issue
of cerclage effectiveness in twin gestations with short CL.
This new, much more detailed meta-analysis solely on
the twin data seems to point mostly to no effect of cerc-
lage, rather than to a detrimental effect. The outcomes
are now reported not only adjusted by confounders, but
also by a random-effects model rather than a fixed one. A
random effects model is now chosen due to the differ-
ences between the studies, and because it has the advanta-
ges of more degrees of freedom providing greater
generalizability of the results (31). That is why the RR for
PTB < 35 weeks is now 1.63 (95% CI 0.88–3.02) with a
random effects model (Table 2), as was used in the
related Cochrane Review (32), instead of 2.15 (95% CI
1.15–4.01) with a fixed effects model, as reported in 2005
(6).
The recent Cochrane meta-analysis of cerclage in twins
showed that placing a circumferential cervical stitch is
not associated with benefits and indeed is associated with
a worse neonatal outcome (32). This meta-analysis
did not evaluate any demographic characteristics or risk
factors, and therefore we did not perform any logistic
regression to correct data for any variables that were sig-
nificantly different between groups. Another meta-analysis
evaluated use of cerclage for preventing PTB in twin
pregnancies (33). This meta-analysis included all RCTs
comparing the effects of cervical cerclage with controls,
including not only women with ultrasound-indicated
cerclage, but also history-indicated cerclage and physical
examination-indicated cerclage, incorporating all the data
in a single analysis. This type of analysis makes clinical
use of such data limited.
Only two non-randomized controlled studies have
been published regarding the efficacy of cerclage com-
pared with no cerclage in twin gestations with second
trimester short maternal TVU CL (34,35). Both reported
no significant effect, neither of benefit or detrimental,
on PTB outcomes. One of the strengths of our study is
inclusion of only RCT data on ultrasound-indicated
cerclage in twins. Most of the studies analyzed had a
low risk of bias as measured by the Cochrane Collabora-
tion’s tools (9). We also used patient-level data. Risk of
publication bias was assessed by visual inspection of the
Forest plot (Figure 3), and the symmetric plot suggested
no publication bias.
Limitations of our study are inherent to those of the
included RCTs, which overall were, however, of good
quality and with low risk of bias. Another limitation is
the small number of twin gestations randomized. All
studies included in our meta-analysis evaluated the effi-
cacy of cerclage not only for twins but also for singleton
pregnancies, but ultrasound-indicated cerclage in twins
has not been studied in a dedicated RCT (19–21). The
only small randomized trial of cerclage on twins evaluated
history-indicated cerclage, and did not show any effect of
cerclage on PTB (18). As the three included trials did not
stratify their randomization sequences for twins, the two
groups were dissimilar in incidence with regard to previ-
ous PTB and gestational age at randomization.
Table 3. Primary outcome in subgroup analyses.
Population Outcome
Cerclage Control
RR (95% CI) aOR (95% CI)n % n %
Prior PTB < 37 weeks PTB < 34 weeks 4/6 66.7 1/1 100 0.86 (0.32–2.27) –
Without previous PTB PTB < 34 weeks 11/18 61.1 5/24 20.8 2.29 (0.35–4.94) –
Prior STL 16–23 weeks PTB < 34 weeks 2/3 66.7 0/0 N/A –
Cone biopsy PTB < 34 weeks 1/2 50.0 1/4 25.0 2.00 (0.22–17.89) –
GA with short CL < 20 weeks PTB < 34 weeks 6/7 85.7 0/1 0 3.25 (0.29–36.67) –
GA with short CL ≥ 20 weeks PTB < 34 weeks 9/17 52.9 6/24 25.0 2.12 (0.93–4.83) –
CL ≤ 15 mm PTB < 34 weeks 6/7 85.7 1/6 16.7 1.74 (1.14–21.57) 1.44 (0.7–8.46)
Logistic regression was performed to correct data for confounders (previous PTB, GA at randomization).
aOR, adjusted odds ratio; CL, cervical length; GA, gestational age; N/A, not applicable; PTB, preterm birth; RR, relative risk, random effect model;
STL, second-trimester loss.
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Conclusion
Based on these Level 1 data, cervical cerclage cannot cur-
rently be recommended for clinical use in twin pregnan-
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